Non-cognitive symptoms and related conditions in the Alzheimer's disease: a literature review.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed, 39 citations in OpenAlex.

1. Dysautonomia in Alzheimer's Disease: A Systematic Review.Brain sciences · 2025
   Review
2. Neurodegenerative disorders, metabolic icebergs, and mitohormesis.Translational neurodegeneration · 2024
   Review
3. Performance of the intracerebroventricularly injected streptozotocin Alzheimer's disease model in a translationally relevant, aged and experienced rat population.Scientific reports · 2022
   Article
4. From Small Peptides to Large Proteins against Alzheimer'sDisease.Biomolecules · 2022
   Review
5. The Relationship Between Muscle Strength and Cognitive Performance Across Alzheimer's Disease Clinical Continuum.Frontiers in neurology · 2022
   Article
6. Pharmacological intervention in a transgenic mouse model improves Alzheimer's-associated pathological phenotype: Involvement of proteasome activation.Free radical biology & medicine · 2021
   Article
7. A pilot protocol to assess the feasibility of a virtual multiple crossover, randomized controlled trial design using methylphenidate in mild cognitive impairment.Trials · 2020
   Article
8. The Effect of Type 2 Diabetes Mellitus on Neuropsychological Symptoms in Chinese Early Alzheimer's Disease Population.Neuropsychiatric disease and treatment · 2020
   Article
9. Suberoylanilide Hydroxamic Acid Triggers Autophagy by Influencing the mTOR Pathway in the Spinal Dorsal Horn in a Rat Neuropathic Pain Model.Neurochemical research · 2019
   Article
10. PINK1 mediates spinal cord mitophagy in neuropathic pain.Journal of pain research · 2019
    Article
11. Exercise as a Positive Modulator of Brain Function.Molecular neurobiology · 2018
    Review
12. TLR4-mediated autophagic impairment contributes to neuropathic pain in chronic constriction injury mice.Molecular brain · 2018
    Article
13. A Comparison of the Behavioral and Psychological Symptoms of Dementia (BPSD) in Early-Onset and Late-Onset Alzheimer's Disease - A Study from South East Asia (Kashmir, India).Cureus · 2016
    Article
14. DISC1 regulates trafficking and processing of APP and Aβ generation.Molecular psychiatry · 2015
    Article
15. "Noncognitive" symptoms of early Alzheimer disease: a longitudinal analysis.Neurology · 2015
    Article
16. Spinal autophagy is differently modulated in distinct mouse models of neuropathic pain.Molecular pain · 2015
    Article
17. Regular exercise prevents non-cognitive disturbances in a rat model of Alzheimer's disease.The international journal of neuropsychopharmacology · 2014
    Article
18. Cotinine halts the advance of Alzheimer's disease-like pathology and associated depressive-like behavior in Tg6799 mice.Frontiers in aging neuroscience · 2014
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as